2019
DOI: 10.1016/j.vaccine.2019.05.084
|View full text |Cite
|
Sign up to set email alerts
|

The advances in brucellosis vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
50
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(52 citation statements)
references
References 109 publications
0
50
0
2
Order By: Relevance
“…Thus, diagnosis relies mainly on serology. Treatment in farm animals is forbidden in many countries and vaccines are not always protective and safe for human health [5]. Eradication programs strictly follow test and slaughter/culling policy.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, diagnosis relies mainly on serology. Treatment in farm animals is forbidden in many countries and vaccines are not always protective and safe for human health [5]. Eradication programs strictly follow test and slaughter/culling policy.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, several studies have been carried out to evaluate immunogenicity and protective responses, as well as the application of immunogenic proteins in the diagnosis of brucellosis [14,85]. For instance, the purified rAdk and rSecB of B. abortus have been proposed to be potential candidates for subunit vaccines [86].…”
Section: Serological Proteome Analysis (Serpa)mentioning
confidence: 99%
“…In the last decade, various types of subunit vaccine candidates utilizing proteomic technology have been proposed. However, some problems regarding the levels of protection and safety remain a matter of open discussion [14].…”
Section: Introductionmentioning
confidence: 99%
“…So far, vaccination has been successful as a control strategy for preventing exposure to brucellosis in regions where the disease is prevalent (3). Consequently, various studies have demonstrated that live Brucella vaccines such as S19, RB51, S2, and Rev.1 are able to effectively offer immune protection against brucellosis and these are therefore widely used around the world (4).…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, various studies have demonstrated that live Brucella vaccines such as S19, RB51, S2, and Rev.1 are able to effectively offer immune protection against brucellosis and these are therefore widely used around the world (4). However, negative implications of these vaccines including diagnostic interference, residual virulence in the host, and pathogenic effects to human health cast doubts to this control strategy (3,(5)(6)(7).…”
Section: Introductionmentioning
confidence: 99%